Sanofi CEO Paul Hudson speaks during the Competing In The Global Marketplace: Strategies for Growth panel, at the Fortune Global Forum on Nov. 11, 2024 in New York City.© Jemal Countess—Getty ...

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's record demand for Dupixent, state of drug innovation in Europe, company outlook, and more.

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

Today we meet with British CEO Paul Hudson to find out how he plans to build the Sanofi of tomorrow.

Sanofi Chief Executive Paul Hudson said the Blueprint acquisition had been in the making for a long time and that work started long before last week’s update.

MORRISTOWN − Gov. Phil Murphy joined Sanofi CEO Paul Hudson on May 22 for the formal grand-opening of French pharmaceutical giant Sanofi's new U.S. flagship office , the home for about 2,000 ...

Sanofi agreed to buy Blueprint Medicines Corp. for at least $9.1 billion as the French drugmaker expands further in rare immunological diseases.

“Sanofi's 13,000 U.S.-based employees are pioneering the research and development of first- and best-in-class medicines across numerous therapeutic areas,” Sanofi CEO Paul Hudson, said in a ...